quinoxalines has been researched along with kallidin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bock, MG; Chang, RS; Dean, DC; Freidinger, RM; Harrell, CM; Hess, JF; Hey, PJ; Jones, AN; Kunapuli, P; Markowitz, MK; Miller, PJ; Murphy, KL; O'Malley, SS; Pettibone, DJ; Raab, CE; Ransom, RW; Reiss, DR; Su, DS; Wallace, MA | 1 |
| Farias, NC; Feres, T; Paiva, AC; Paiva, TB | 1 |
2 other study(ies) available for quinoxalines and kallidin
| Article | Year |
|---|---|
Pharmacological characterization and radioligand binding properties of a high-affinity, nonpeptide, bradykinin B1 receptor antagonist.
Topics: Animals; Aorta, Thoracic; Binding, Competitive; Blood Pressure; Bradykinin B1 Receptor Antagonists; CHO Cells; Cricetinae; Cricetulus; Dogs; Dose-Response Relationship, Drug; Humans; Imidazoles; In Vitro Techniques; Kallidin; Lipopolysaccharides; Male; Quinoxalines; Rabbits; Radioligand Assay; Rats; Receptor, Bradykinin B1; Transfection; Tritium; Vasoconstriction | 2004 |
Lys-[Leu8,des-Arg9]-bradykinin blocks lipopolysaccharide-induced SHR aorta hyperpolarization by inhibition of Ca(++)- and ATP-dependent K+ channels.
Topics: Acetylcholine; Adenosine Triphosphate; Animals; Aorta, Thoracic; Bradykinin; Brimonidine Tartrate; Cromakalim; Dose-Response Relationship, Drug; Endothelium, Vascular; In Vitro Techniques; Kallidin; Lipopolysaccharides; Male; Membrane Potentials; Peptides; Potassium Channels, Calcium-Activated; Quinoxalines; Rats; Rats, Inbred SHR; Rats, Wistar; Vasodilator Agents | 2004 |